A biotech company operates from a location in Waltham.
2 reports, 2 independent
Updated Sep 2
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A biotech company operates from a location in Waltham.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Cronus Pharma LLC, headquartered in East Brunswick, is launching products in the U.S. market and seeking FDA approval.
- BioXcel Therapeutics received FDA approval for its drug and announced results from New Haven.
- BioPorto is seeking regulatory pathways and activating its first clinical site in collaboration with Massachusetts General Hospital.
- UroGen Pharma Ltd., headquartered in Princeton, is seeking FDA approval for its products for the U.S. market.
- Biocon's subsidiary received FDA approval for a drug in the United States on August 18, 2026.